Autres langues

14/07 Graphene Manufacturing (TSXV: GMG) (OTCQX: GMGMF) Reports Record Sales, Expands Graphene Production and Advances Commercial Growth
13/07 Pulsenmore Selected For Israel Innovation Authority And Ministry Of Health Program To Lead $1 Million AI Development Project
02/07 Pulsenmore Files Resale Registration for 3.1 Million Shares
26/06 Pulsenmore Ltd. announced that it has received $7.499844 million in funding
25/06 Pulsenmore to Raise $7.5 Million in Equity Private Placement
25/06 Peraso (NASDAQ: PRSO) Could Be One of the Most Overlooked AI Infrastructure and Military Drone Stocks Under $1 - More Stocks Inside
25/06 Pulsenmore Ltd. announced that it expects to receive $7.499844 million in funding
24/06 Top Midday Gainers
24/06 Pulsenmore Enters Partnership with Ouma Health for its Home Ultrasound Platform; Shares Rise Pre-Bell
24/06 Pulsenmore Ltd. And Ouma Health Enter Strategic Partnership To Expand Access To Remote Prenatal Care Across The United States
30/03 Pulsenmore : Corporate Presentation (Pulsenmore Investor Deck 03302026 )
30/03 Pulsenmore Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
18/03 Pulsenmore : Announces Full Year 2025 Earnings Conference Call
09/02 Pulsenmore Ltd. Enters Commercial Engagement With TLC Perinatal For Home Ultrasound Services In U.S
02/02 Pulsenmore Ltd. Announces First Commercial Engagement with a Leading U.S. Based Medical Center
26/01 Pulsenmore Ltd. and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation
22/01 Wall Street Set to Open Higher Thursday as Investors Parse GDP, Unemployment Data, Look Ahead to Inflation Report
22/01 Investors Await Raft of Key Economic Data as US Futures Rise Thursday Pre-Bell
22/01 Pulsenmore Ltd.(NasdaqCM:PLSM) added to NASDAQ Composite Index
21/01 Pulsenmore Ltd. will Change its Ticker to PLSM from PULS
29/12 Pulsenmore Ltd says filing registration statement in anticipation of listing of ordinary shares on Nasdaq
03/11 Pulsenmore Ltd. Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S
03/11 Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S.
31/08/25 Pulsenmore Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
30/03/25 Pulsenmore Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
Aucun résultat pour cette recherche